These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1503443)

  • 1. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
    Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.
    Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.
    Daluge SM; Good SS; Faletto MB; Miller WH; St Clair MH; Boone LR; Tisdale M; Parry NR; Reardon JE; Dornsife RE; Averett DR; Krenitsky TA
    Antimicrob Agents Chemother; 1997 May; 41(5):1082-93. PubMed ID: 9145874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
    van Wijk GM; Hostetler KY; Kroneman E; Richman DD; Sridhar CN; Kumar R; van den Bosch H
    Chem Phys Lipids; 1994 Apr; 70(2):213-22. PubMed ID: 8033292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I dose-escalation pharmacokinetics of AZT-P-ddI (IVX-E-59) in patients with human immunodeficiency virus.
    Zhou XJ; Squires K; Pan-Zhou XR; Bernhard S; Agrofoglio L; Kirk M; Duchin KL; Sommadossi JP
    J Clin Pharmacol; 1997 Mar; 37(3):201-13. PubMed ID: 9089422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys.
    Boudinot FD; Schinazi RF; Gallo JM; McClure HM; Anderson DC; Doshi KJ; Kambhampathi PC; Chu CK
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):219-28. PubMed ID: 2328158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
    Spector SA; Ripley D; Hsia K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
    McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
    J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
    Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
    J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the inhibition of replication of HIV and MuLV by some 3'-blocked pyrimidine analogs.
    Bazin H; Chattopadhyaya J; Datema R; Ericson AC; Gilljam G; Johansson NG; Hansen J; Koshida R; Moelling K; Oberg B
    Biochem Pharmacol; 1989 Jan; 38(1):109-19. PubMed ID: 2462876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine.
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.
    Kim EY; Vrang L; Oberg B; Merigan TC
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):401-7. PubMed ID: 11282008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
    Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
    J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
    August EM; Birks EM; Prusoff WH
    Mol Pharmacol; 1991 Feb; 39(2):246-9. PubMed ID: 1847498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition in animals of a new anti-HIV agent: 2',3'-didehydro-3'-deoxythymidine.
    Russell JW; Whiterock VJ; Marrero D; Klunk LJ
    Drug Metab Dispos; 1990; 18(2):153-7. PubMed ID: 1971565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
    Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP
    Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
    Perno CF; Yarchoan R; Cooney DA; Hartman NR; Gartner S; Popovic M; Hao Z; Gerrard TL; Wilson YA; Johns DG
    J Exp Med; 1988 Sep; 168(3):1111-25. PubMed ID: 2844951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.